The 2026 update to the ADA’s Standards of Care in Diabetes introduces new guidance on a wide range of topics, including the ...

The 2026 update reflects rapid advancements in diabetes care, with a strong emphasis on personalized treatment, technology ...

BERLIN — New consensus guidelines on patient-centered management of type 2 diabetes have now been published for clinicians in Europe and the United States. The final version of the document, ...

Diabetic neuropathy is the most common complication of diabetes, yet there’s a lack of targeted treatment options. Distal symmetric polyneuropathy and diabetic autonomic neuropathy are particularly ...

Today, the American Diabetes Association (R) (ADA) released the "Standards of Care in Diabetes--2026" (Standards of Care), the gold standard in evidence-based guidelines for diagnosing and managing ...

Pre-exercise medical clearance is generally unnecessary for asymptomatic individuals prior to beginning low-intensity or moderate-intensity physical activity not exceeding the demands of brisk walking ...

Type 1 diabetes diagnosis It is critical for us to remember that children are not little adults. Pediatric-onset diabetes is different from adult-onset diabetes due to its distinct epidemiology, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The 2025 ADA Standards of Care includes updated ...

The American Diabetes Association (ADA) today offered a position statement on treating diabetes and hypertension for the first time since 2003. The American Diabetes Association (ADA) today offered a ...

The recommendation to limit long periods of sitting comes after multiple studies show how it affects blood glucose management. ADA also gives providers charts to help them understand the cost of ...

A new version of Medtronic’s advanced, hybrid closed-loop insulin delivery system showed it could help improve blood sugar control throughout the day in adolescents and young adults with Type 1 ...